- Home
- XOMA
XOMA
XOMA Corporation
as 05-30-2025 4:00pm EST
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 300.5M | IPO Year: | N/A |
| Target Price: | $69.50 | AVG Volume (30 days): | 46.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.35 - $35.00 | Next Earning Date: | 05-13-2025 |
| Revenue: | $42,909,000 | Revenue Growth: | 638.41% |
| Revenue Growth (this year): | 24.96% | Revenue Growth (next year): | 26.75% |
Latest XOMA Corporation News
XOMA Breaking Stock News: Dive into XOMA Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
Argus Research
11 days ago
Daily – Vickers Top Buyers & Sellers for 05/21/2025
Simply Wall St.
16 days ago
Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
Simply Wall St.
17 days ago
XOMA Royalty First Quarter 2025 Earnings: Beats Expectations
Zacks
19 days ago
XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates
Associated Press Finance
19 days ago
XOMA Royalty: Q1 Earnings Snapshot
GlobeNewswire
19 days ago
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
GlobeNewswire
25 days ago
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
Compare XOMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XOMA XOMA Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.